ACCORD HEALTHCARE C/O UPD LEA GLEN — Citalopram Importer Profile
Pharmaceutical Importer · #15 buyer for Citalopram · $296.1K import value · 22 shipments · SOUTH AFRICA · DGFT Verified
ACCORD HEALTHCARE C/O UPD LEA GLEN is the #15 importer of Citalopram from India with $296.1K in import value and 22 verified shipments. ACCORD HEALTHCARE C/O UPD LEA GLEN holds a 0.4% market share in Citalopram imports based in SOUTH AFRICA. The company sources from 1 verified supplier across 9 formulations shipped to 1 country. Overall, ACCORD HEALTHCARE C/O UPD LEA GLEN imports 2 pharmaceutical products worth $2.2M across 1 therapeutic categories.
ACCORD HEALTHCARE C/O UPD LEA GLEN — Citalopram Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Citalopram to ACCORD HEALTHCARE C/O UPD LEA GLEN?
Verified from 22 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED | $296.1K | 22 | 100.0% |
ACCORD HEALTHCARE C/O UPD LEA GLEN sources Citalopram from 1 verified Indian supplier based on 22 customs records. The primary supplier is INTAS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
Where Does ACCORD HEALTHCARE C/O UPD LEA GLEN Import Citalopram To?
Destination countries from 22 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $296.1K | 22 | 100.0% |
ACCORD HEALTHCARE C/O UPD LEA GLEN imports Citalopram to 1 country. The primary destination is SOUTH AFRICA receiving 100.0% of shipments worth $296.1K.
What Citalopram Formulations Does ACCORD HEALTHCARE C/O UPD LEA GLEN Import?
| Formulation | Value | Shipments |
|---|---|---|
| PH.DRU.& MED.: ACCORD ESCITALOPRAM TABLETS 20MG (EACH TABLET CONTAINS: ESCITALOPRAM 20MG) [2X14T PER PACK] | $100.0K | 2 |
| PH.DRU.& MED.: ACCORD ESCITALOPRAM TABLETS 10MG (EACH TABLET CONTAINS: ESCITALOPRAM 10MG) [2X14T PER PACK] | $100.0K | 2 |
| PHARMA DRUGS & MEDI ACCORD ESCITALOPRAM20 AS PER INVOICE | $30.4K | 3 |
| PHARM DRUG&MED:ACCORD ESCITALOPRAM 20 EACH FILM COATED TABLET CONT:ESCITALOPRAMOXALATE EQUIVALENT TO ESCITALOPRAM 20MGTBS | $18.6K | 3 |
| PHARMA DRUGS & MEDI ACCORD ESCITALOPRAM 10 AS PER INVOICE | $15.3K | 1 |
| PHARM DRUG&MED:ACCORD ESCITALOPRAM 10 EACH FILM COATED TABLET CONT:ESCITALOPRAMOXALATE EQUIVALENT TO ESCITALOPRAM 10MGTBS | $13.9K | 3 |
| PHARMA DRUGS AND MEDI ACCORD ESCITALOPRAM 10 AS PER INVOICE | $7.6K | 3 |
| PHARMA DRUGS & MEDI ACCORD ESCITALOPRAM 20 AS PER INVOICE | $5.9K | 2 |
| PH.DRU.& MED.: ACCORD ESCITALOPRAM TABLETS 10MG (EACH TABLET CONTAINS: ESCITALOPRAM 10MG) [2X14T PER PACK]TBS | $4.4K | 3 |
ACCORD HEALTHCARE C/O UPD LEA GLEN imports 9 distinct Citalopram formulations from India. The top formulation is PH.DRU.& MED.: ACCORD ESCITALOPRAM TABLETS 20MG (EACH TABLET with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Citalopram into South Africa
What ACCORD HEALTHCARE C/O UPD LEA GLEN and other importers must comply with to import Citalopram from India
Regulatory Authority
South African Health Products Regulatory Authority (SAHPRA)
Approval Process for Generic Citalopram
Registration of generic medicines under SAHPRA guidelines based on CTD format. Bioequivalence required for generic applications.
Typical timeline: 24–48 months (significant backlog)
GMP Requirements
WHO GMP or PIC/S GMP compliance; SAHPRA may conduct overseas inspection
Import Licence & Documentation
Import permit from SAHPRA per Section 22A of the Medicines Act
Labeling & Packaging
English language labeling; SAHPRA scheduling status displayed
Note: SAHPRA has a known registration backlog. WHO Prequalification of the product or PIC/S certification of the site significantly assists the process.
Regulatory information is provided for general reference based on publicly available SAHPRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with SAHPRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Citalopram from India and How Much Does ACCORD HEALTHCARE C/O UPD LEA GLEN Import?
India exported $54.8M worth of Citalopram through 7,372 shipments from 257 suppliers to 101 countries, serving 736 buyers globally. ACCORD HEALTHCARE C/O UPD LEA GLEN imports $296.1K of this total, accounting for 0.4% of India's Citalopram exports with 22 shipments from SOUTH AFRICA. This is verified from 22 customs shipment records covering 9 distinct formulations.
What Is the Average Order Value for ACCORD HEALTHCARE C/O UPD LEA GLEN's Citalopram Imports?
ACCORD HEALTHCARE C/O UPD LEA GLEN's average Citalopram order value is $13.5K per consignment, based on 22 shipments totaling $296.1K. ACCORD HEALTHCARE C/O UPD LEA GLEN is based in SOUTH AFRICA and ranks #15 among all Citalopram importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Citalopram to ACCORD HEALTHCARE C/O UPD LEA GLEN?
ACCORD HEALTHCARE C/O UPD LEA GLEN sources Citalopram from 1 verified Indian supplier: INTAS PHARMACEUTICALS LIMITED ($296.1K, 100.0%). This is based on 22 customs records.
How Does ACCORD HEALTHCARE C/O UPD LEA GLEN Compare to Other Citalopram Importers?
ACCORD HEALTHCARE C/O UPD LEA GLEN ranks #15 among 736 Citalopram importers from India with a 0.4% market share. The top 3 importers are YUSEN LOGISTICS BENELUX BELGIUM ($8.9M), TORRENT PHARMA INC ($7.3M), LEK S.A. ($4.1M). ACCORD HEALTHCARE C/O UPD LEA GLEN processed 22 shipments from SOUTH AFRICA.
What Other CNS & Psychiatric Products Does ACCORD HEALTHCARE C/O UPD LEA GLEN Import?
ACCORD HEALTHCARE C/O UPD LEA GLEN also imports these cns & psychiatric products. Each links to the detailed product page.
About ACCORD HEALTHCARE C/O UPD LEA GLEN
ACCORD HEALTHCARE C/O UPD LEA GLEN imports 2 products worth $2.2M. Beyond Citalopram, top products include Escitalopram. View the complete ACCORD HEALTHCARE C/O UPD LEA GLEN profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Citalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Citalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ACCORD HEALTHCARE C/O UPD LEA GLEN matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ACCORD HEALTHCARE C/O UPD LEA GLEN's capped import value divided by total capped export value for Citalopram across all Indian exporters.
- 5.Verified Records: This page is backed by 22 individual customs records matching ACCORD HEALTHCARE C/O UPD LEA GLEN importing Citalopram, covering 9 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 736+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Citalopram Import Data for ACCORD HEALTHCARE C/O UPD LEA GLEN
Access order-level details, pricing data, supplier connections, and competitive analysis for ACCORD HEALTHCARE C/O UPD LEA GLEN's Citalopram imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ACCORD HEALTHCARE C/O UPD LEA GLEN
Full Company Profile →
2 products · $2.2M total trade · 1 categories
ACCORD HEALTHCARE C/O UPD LEA GLEN × Citalopram
Verified from customs records
Company Overview
Top Products by ACCORD HEALTHCARE C/O UPD LEA GLEN
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ACCORD HEALTHCARE C/O UPD LEA GLEN.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Citalopram. For current order-level data, contact TransData Nexus.